Henry O’Connell, CEO and co-founder of Canary Speech
Vocal biomarker data has come a long way in a short amount of time. No longer relegated to the pages of science fiction, the power of the…
Continue Reading
Sjögren’s disease (SjD) is a common systemic autoimmune disease that remains difficult to diagnose early due to non-specific symptoms and lack of definitive biomarkers. This multicentre retrospective cohort study analysed data from 34,958 patients…
Continue Reading
What You Should Know:
– Function has created a new category in preventive health—one that shifts how people think about longevity, early detection, and everyday decision-making. The company’s mission is simple but ambitious: empower people to…
Continue Reading
Accurately predicting surgical and transfusion needs in traumatic brain injury (TBI) patients remains challenging in emergency settings. We developed multiomics data fusion (MDF) models integrating clinical biomarkers, neural radiological imaging, and clinical text mining…
Continue Reading
Introduction to Precision Medicine Innovation
The healthcare landscape is experiencing a transformative shift as technology-driven companies promise to revolutionize how we understand and manage our health. A growing number of organizations offer sophisticated solutions for…
Continue Reading
This systematic review explores the relationship between digital biomarkers, measured using wearable devices, and fatigue in patients with chronic diseases. Studies included in this review focused on individuals with diseases or conditions in 13…
Continue Reading
Depressed mood and anhedonia, the core symptoms of major depressive disorder (MDD), are linked to dysfunction in the brain’s reward and emotion regulation circuits. To develop a predictive model for treatment remission in MDD…
Continue Reading
Dr. Richard S. Isaacson, Neurologist at The Institute for Neurodegenerative Diseases (IND)
Dr. Kellyann Niotis M.D. Neurologist at The Institute for Neurodegenerative Diseases (IND)
Hundreds of millions of people worldwide live with a high risk of…
Continue Reading
Elisabeth Thijssen, PhD, Chief Scientific Officer of Neurogen Biomarking.
What You Should Know:
– Advancements in accelerating early Alzheimer’s disease (AD) screening and access to care, proven from three diverse community pilot initiatives, were presented today…
Continue Reading
Sepsis, a life-threatening disease caused by infection, presents a major global health challenge due to its high morbidity and mortality rates. A rapid and precise diagnosis of sepsis is essential for better patient outcomes….
Continue Reading
